Significant hypomethylation of TNFAIP8 and increased expression in the placenta and peripheral blood cells from early-onset preeclamptic patients

International Journal of Clinical and Experimental Medicine

Volumn 9, Issue 6, 2016, Pages 10384-10393

  Lin, Liang ^a,b   Yu, Yanhong ^a   Zhang, Zhenhai ^a   Yang, Yin ^b  

^a FIRST MILITARY MEDICAL UNIVERSITY   (China)

^b FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Methylation; Peripheral blood; Placenta; Preeclampsia; TNFAIP8

Indexed keywords

BETA ACTIN; DNA; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INDUCED PROTEIN 8; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; EARLY ONSET PREECLAMPSIA; ENDOTHELIUM CELL; FEMALE; GENE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LATE ONSET PREECLAMPSIA; MICROSCOPY; PERIPHERAL BLOOD STEM CELL; PLACENTA; PREECLAMPSIA; PREGNANCY; PROTEIN EXPRESSION; PYROSEQUENCING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYNCYTIOTROPHOBLAST; TNFAIP8 GENE; WESTERN BLOTTING;

EID: 84977103348     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Sibai B, Dekker G and Kupferminc M. Pre-eclampsia. Lancet 2005; 365: 785-799.
2. Huppertz B. Placental origins of preeclampsia: challenging the current hypothesis. Hypertension 2008; 51: 970-975.
3. Roberts JM and Escudero C. The placenta in preeclampsia. Pregnancy Hypertens 2012; 2: 72-83.
4. Roberts DJ and Post MD. The placenta in pre-eclampsia and intrauterine growth restriction. J Clin Pathol 2008; 61: 1254-1260.
5. Boulanger H and Flamant M. [New insights in the pathophysiology of preeclampsia and potential therapeutic implications]. Nephrol Ther 2007; 3: 437-448.
6. Kucukgoz Gulec U, Ozgunen FT, Buyukkurt S, Guzel AB, Urunsak IF, Demir SC and Evruke IC. Comparison of clinical and laboratory findings in early- and late-onset preeclampsia. J Matern Fetal Neonatal Med 2013; 26: 1228-1233.
7. Ogge G, Chaiworapongsa T, Romero R, Hussein Y, Kusanovic JP, Yeo L, Kim CJ and Hassan SS. Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsia. J Perinat Med 2011; 39: 641-652.
8. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev 2002; 16: 6-21.
9. Bird AP. CpG-rich islands and the function of DNA methylation. Nature 1986; 321: 209-213.
10. Hoegh AM, Borup R, Nielsen FC, Sorensen S and Hviid TV. Gene expression profiling of placentas affected by pre-eclampsia. J Biomed Biotechnol 2010; 2010: 787545.
11. Liu L, Zhang X, Rong C, Rui C, Ji H, Qian YJ, Jia R and Sun L. Distinct DNA methylomes of human placentas between pre-eclampsia and gestational diabetes mellitus. Cell Physiol Biochem 2014; 34: 1877-1889.
12. Kumar D, Gokhale P, Broustas C, Chakravarty D, Ahmad I and Kasid U. Expression of SCC-S2, an antiapoptotic molecule, correlates with enhanced proliferation and tumorigenicity of MDA-MB 435 cells. Oncogene 2004; 23: 612-616.
13. You Z, Ouyang H, Lopatin D, Polver PJ and Wang CY. Nuclear factor-kappa B-inducible death effector domain-containing protein suppresses tumor necrosis factor-mediated apoptosis by inhibiting caspase-8 activity. J Biol Chem 2001; 276: 26398-26404.
14. Miao Z, Zhao T, Wang Z, Xu Y, Song Y, Wu J and Xu H. SCC-S2 is overexpressed in colon cancers and regulates cell proliferation. Tumour Biol 2012; 33: 2099-2106.
15. Hadisaputri YE, Miyazaki T, Suzuki S, Yokobori T, Kobayashi T, Tanaka N, Inose T, Sohda M and Kuwano H. TNFAIP8 overexpression: clinical relevance to esophageal squamous cell carcinoma. Ann Surg Oncol 2012; 19 Suppl 3: S589-596.
16. Liu T, Gao H, Yang M, Zhao T, Liu Y and Lou G. Correlation of TNFAIP8 overexpression with the proliferation, metastasis, and disease-free survival in endometrial cancer. Tumour Biol 2014; 35: 5805-5814.
17. Faas MM, Spaans F and De Vos P. Monocytes and macrophages in pregnancy and pre-eclampsia. Front Immunol 2014; 5: 298.
18. Yuen RK, Penaherrera MS, von Dadelszen P, McFadden DE and Robinson WP. DNA methylation profiling of human placentas reveals promoter hypomethylation of multiple genes in early-onset preeclampsia. Eur J Hum Genet 2010; 18: 1006-1012.
19. Dieber-Rotheneder M, Beganovic S, Desoye G, Lang U and Cervar-Zivkovic M. Complex expression changes of the placental endothelin system in early and late onset preeclampsia, fetal growth restriction and gestational diabetes. Life Sci 2012; 91: 710-715.
20. Blair JD, Yuen RK, Lim BK, McFadden DE, von Dadelszen P and Robinson WP. Widespread DNA hypomethylation at gene enhancer regions in placentas associated with early-onset pre-eclampsia. Mol Hum Reprod 2013; 19: 697-708.
21. Xiang Y, Zhang X, Li Q, Xu J, Zhou X, Wang T, Xing Q, Liu Y, Wang L, He L and Zhao X. Promoter hypomethylation of TIMP3 is associated with pre-eclampsia in a Chinese population. Mol Hum Reprod 2013; 19: 153-159.
22. Geng J, Hu T, Wang B, Lu W and Ma S. Thyroid stimulating hormone levels and risk of coronary heart disease in patients with type 2 diabetes mellitus. Int J Cardiol 2014; 174: 851-853.
23. Xiang Y, Cheng Y, Li X, Li Q, Xu J, Zhang J, Liu Y, Xing Q, Wang L, He L and Zhao X. Up-regulated expression and aberrant DNA methylation of LEP and SH3PXD2A in pre-eclampsia. PLoS One 2013; 8: e59753.
24. Wang Z, Lu S, Liu C, Zhao B, Pei K, Tian L and Ma X. Expressional and epigenetic alterations of placental matrix metalloproteinase 9 in preeclampsia. Gynecol Endocrinol 2010; 26: 96-102.
25. Zhuang XW, Li J, Brost BC, Xia XY, Chen HB, Wang CX and Jiang SW. Decreased expression and altered methylation of syncytin-1 gene in human placentas associated with preeclampsia. Curr Pharm Des 2014; 20: 1796-1802.
26. Germain SJ, Sacks GP, Sooranna SR, Sargent IL and Redman CW. Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles. J Immunol 2007; 178: 5949-5956.
27. LaMarca BD, Gilbert J and Granger JP. Recent progress toward the understanding of the pathophysiology of hypertension during preeclampsia. Hypertension 2008; 51: 982-988.
28. Escudero C, Celis C, Saez T, San Martin S, Valenzuela FJ, Aguayo C, Bertoglia P, Roberts JM and Acurio J. Increased placental angiogenesis in late and early onset pre-eclampsia is associated with differential activation of vascular endothelial growth factor receptor 2. Placenta 2014; 35: 207-215.
29. Palei AC, Granger JP and Tanus-Santos JE. Matrix metalloproteinases as drug targets in preeclampsia. Curr Drug Targets 2013; 14: 325-334.
30. Zhang C, Chakravarty D, Sakabe I, Mewani RR, Boudreau HE, Kumar D, Ahmad I and Kasid UN. Role of SCC-S2 in experimental metastasis and modulation of VEGFR-2, MMP-1, and MMP-9 expression. Mol Ther 2006; 13: 947-955.
31. Cackovic M, Buhimschi CS, Zhao G, Funai EF, Norwitz ER, Kuczynski E, Lockwood CJ and Buhimschi IA. Fractional excretion of tumor necrosis factor-alpha in women with severe preeclampsia. Obstet Gynecol 2008; 112: 93-100.